The safety and tolerability of an HIV-1 DNA Prime-Protein Boost Vaccine (DP6-001) in healthy adult volunteers

This report describes the safety observations following administration of a polyvalent DNA prime-protein boost HIV-1 vaccine formulated with adjuvant QS21. Local injection site reactionswere the most common (65% of subjects), and included type IV delayed-type hypersensitivity (DTH) reactions at prio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kennedy, Jeffrey S., Co, Mary, Green, Sharone, Longtine, Karen, Longtine, Jaclyn, O’Neill, Melissa A., Adams, Janice P., Rothman, Alan L., Yu, Qiao, Johnson-Leva, Renita, Pal, Ranajit, Wang, Shixia, Lu, Shan, Markham, Phillip
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2571083/
https://ncbi.nlm.nih.gov/pubmed/18588934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.05.090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars